However, in our experience, the translational clock usually ticks faster when there is a clinician on the translational team who is acutely aware of how short the timeline is for many who suffer from lethal, progressive diseases, or when basic scientists interact with patients and their families through meetings organized by advocacy groups (Gordon et al., 2008).